Avricore Health (AVCRF) Invested Capital (2013 - 2025)

Avricore Health has disclosed Invested Capital across 12 years of filings, most recently posting $939833.3 for Q3 2025.

• In Q3 2025, Invested Capital fell 48.48% year-over-year to $939833.3; the TTM figure through Dec 2025 stood at $95921.4 (down 93.19% YoY), while the FY2025 annual figure was $939833.3, changed N/A from the prior year.
• Invested Capital fell to $939833.3 in Q3 2025, from $1.2 million in the prior quarter.
• Over the last five years, Invested Capital for AVCRF reached as high as $1.8 million in Q3 2024 and fell as low as $31604.0 in Q1 2021.
• The 5-year median for Invested Capital is $1.4 million (2024), against an average of $1.2 million.
• Annual changes were most pronounced in 2021 — Invested Capital sank 76.52% — and 2022, when it jumped 5136.71%.
• A 5-year view of Invested Capital shows it stood at $1.8 million in 2021, then fell by 16.8% to $1.5 million in 2022, then climbed by 9.69% to $1.6 million in 2023, then slipped by 13.02% to $1.4 million in 2024, then sank by 33.28% to $939833.3 in 2025.
• According to Business Quant data, Invested Capital over the past three periods registered $939833.3, $1.2 million, and $1.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.